RxDoctor Payments Data

Boyd Johnson, DO

Family Medicine · Exeter, CANPI 1215015482

Payments from drug & device makers

$1,806in general payments, 2019–2025

Across 113 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$292
  • Pfizer$209
  • Lilly USA, LLC$158
  • Amgen$142
  • GSK$142
  • Merck$107
  • plus $756 from 19 others

What the payments were for

  • Food & beverage$1,806100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,806 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$286,772
Medicare patients
777
Services billed
2,838

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin11$34,832
EliquisApixaban74$28,788
JanuviaSitagliptin Phosphate26$23,582
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$18,858
MounjaroTirzepatide18$16,407
Breo ElliptaFluticasone/Vilanterol30$14,735
FarxigaDapagliflozin Propanediol59$14,116
JardianceEmpagliflozin20$12,350
Combivent RespimatIpratropium/Albuterol Sulfate17$8,518
Tresiba Flextouch U-100Insulin Degludec25$6,965
MyrbetriqMirabegron51$5,926
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$3,747
Albuterol Sulfate HfaAlbuterol Sulfate90$3,362
Memantine Hcl ErMemantine Hcl152$2,533
Lubiprostone14$2,501

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$25$34,83211 claims
GSKTrelegy Ellipta, Breo Ellipta$142$33,59346 claims
PfizerEliquis$209$28,78874 claims
MerckJanuvia$107$23,58226 claims
Boehringer IngelheimJardiance, Combivent Respimat$85$20,86837 claims
AstraZenecaFarxiga, Brilinta$99$16,52880 claims
Lilly USA, LLCMounjaro$158$16,40718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,533 family medicine providers in California.

Other family medicine in Exeter

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →